Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 5, 2011, Pages 1003-1016

  Touvier, Mathilde ^a,b   Chan, Doris S M ^a   Lau, Rosa ^a   Aune, Dagfinn ^a   Vieira, Rui ^a   Greenwood, Darren C ^c   Kampman, Ellen ^d   Riboli, Elio ^a   Hercberg, Serge ^b   Norat, Teresa ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; POLYADENYLIC ACID; PROTEIN; PROTEIN APAI; PROTEIN BSMI; PROTEIN FOKI; PROTEIN TAQI; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; CANCER INCIDENCE; CANCER RISK; COLORECTAL CANCER; DISEASE ASSOCIATION; DOSE RESPONSE; HUMAN; MEDLINE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN INTAKE;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; GENOTYPE; HUMANS; INCIDENCE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; RISK FACTORS; VITAMIN D;

EID: 79955782307     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1141     Document Type: Article

References (99)

1. Parkin DM, Ferlay J, Curado MP, Bray F, Edwards B, Shin HR, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010.[Epub ahead of print].
2. AICR/WCRF. American Institute for Cancer Research/World Cancer Research Fund - food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.
3. Butler LM, Wang R, Koh WP, Yu MC. Prospective study of dietary patterns and colorectal cancer among Singapore Chinese. Br J Cancer 2008;99:1511-6.
4. Ishihara J, Inoue M, Iwasaki M, Sasazuki S, Tsugane S. Dietary calcium, vitamin D, and the risk of colorectal cancer. Am J Clin Nutr 2008;88:1576-83.
5. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 2010;340:b5500.
6. McCarl M, Harnack L, Limburg PJ, Anderson KE, Folsom AR. Incidence of colorectal cancer in relation to glycemic index and load in a cohort of women. Cancer Epidemiol Biomarkers Prev 2006;15:892-6. (Pubitemid 43823514)
7. Park SY, Murphy SP, Wilkens LR, Nomura AM, Henderson BE, Kolonel LN, et al. Calcium and vitamin D intake and risk of colorectal cancer: the multiethnic cohort study. Am J Epidemiol 2007;165:784-93. (Pubitemid 46434607)
8. Huncharek M, Muscat J, Kupelnick B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a metaanalysis of 26,335 cases from 60 observational studies. Nutr Cancer 2009;61:47-69.
9. Gazzaniga P, Naso G, Gradilone A, Cortesi E, Gandini O, Gianni W, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2010.[Epub ahead of print].
10. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007;32:210-6. (Pubitemid 46223622)
11. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H, et al. Metaanalysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 2009;30:113-25.
12. Woolcott CG, Wilkens LR, Nomura AM, Horst RL, Goodman MT, Murphy SP, et al. Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2010;19:130-4.
13. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28. (Pubitemid 44699167)
14. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 2005;97:179-94.
15. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006;147:5542-8. (Pubitemid 44833469)
16. Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J, et al. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 2009;29:3511-36.
17. McCullough ML, Bostick RM, Mayo TL. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr 2009;29:111-32.
18. Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 2009;30:1170-80.
19. Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, et al. Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of vitamin D intake mediated through VDR binding. Int J Cancer 2008;123:2170-9.
20. Hughes DJ, Hlavata I, Soucek P, Pardini B, Naccarati A, Vodickova L, et al. Variation in the vitamin D receptor gene is not associated with risk of colorectal cancer in the Czech Republic. J Gastrointest Cancer 2010.[Epub ahead of print].
21. Jenab M, McKay J, Bueno-de-Mesquita HB, van Duijnhoven FJ, Ferrari P, Slimani N, et al. Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. Cancer Epidemiol Biomarkers Prev 2009;18:2485-91.
22. Poynter JN, Jacobs ET, Figueiredo JC, Lee WH, Conti DV, Campbell PT, et al. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010;19:525-36.
23. WCRF-AICR The Continuous Update Project. Available from: http://www.dietandcancerreport.org/cu/.
24. The associations between food, nutrition and physical activity and the risk of colorectal cancer and underlying mechanisms - Systematic Literature Review Report (August, 2006). Available from: http://www.dietandcancerreport. org/downloads/SLR/Colon-and-Rectum-SLR.pdf.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
26. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135:1301-9.
27. Bekkering GE, Harris RJ, Thomas S, Mayer AM, Beynon R, Ness AR, et al. How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis?Am J Epidemiol 2008;167:1017-26.
28. McCullough ML, Robertson AS, Rodriguez C, Jacobs EJ, Chao A, Carolyn J, et al. Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 2003;14:1-12. (Pubitemid 36403263)
29. Bostick RM, Potter JD, Sellers TA, McKenzie DR, Kushi LH, Folsom AR, et al. Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study. Am J Epidemiol 1993;137:1302-17. (Pubitemid 23215031)
30. Kearney J, Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, et al. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 1996;143:907-17. (Pubitemid 26131098)
31. Sellers TA, Bazyk AE, Bostick RM, Kushi LH, Olson JE, Anderson KE, et al. Diet and risk of colon cancer in a large prospective study of older women: an analysis stratified on family history (Iowa, United States). Cancer Causes Control 1998;9:357-67. (Pubitemid 28466687)
32. Zheng W, Anderson KE, Kushi LH, Sellers TA, Greenstein J, Hong CP, et al. A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:221-5. (Pubitemid 28353932)
33. Hamling J, Lee P, Weitkunat R, Ambuhl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 2008;27:954-70. (Pubitemid 351395458)
34. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
35. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
36. Royston P. A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med 2000;19:1831-47. (Pubitemid 30448192)
37. Kesse E, Boutron-Ruault MC, Norat T, Riboli E, Clavel-Chapelon F. Dietary calcium, phosphorus, vitamin D, dairy products and the risk of colorectal adenoma and cancer among French women of the E3NEPIC prospective study. Int J Cancer 2005;117:137-44. (Pubitemid 41262767)
38. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004;13:1502-8. (Pubitemid 39202318)
39. Glynn SA, Albanes D, Pietinen P, Brown CC, Rautalahti M, Tangrea JA, et al. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 1996;5:487-94. (Pubitemid 26235013)
40. Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007;99:1594-602.
41. Sweeney C, Curtin K, Murtaugh MA, Caan BJ, Potter JD, Slattery ML, et al. Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 2006;15:744-9.
42. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O, et al. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985;1:307-9.
43. Heilbrun LK, Nomura A, Hankin JH, Stemmermann GN. Diet and colorectal cancer with special reference to fiber intake. Int J Cancer 1989;44:1-6. (Pubitemid 19184668)
44. Martínez ME, Giovannucci EL, Colditz GA, Stampfer MJ, Hunter DJ, Speizer FE, et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst 1996;88:1375-82. (Pubitemid 26329755)
45. Terry P, Baron JA, Bergkvist L, Holmberg L, Wolk A. Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer 2002;43:39-46. (Pubitemid 35387254)
46. Jarvinen R, Knekt P, Hakulinen T, Aromaa A. Prospective study on milk products, calcium and cancers of the colon and rectum. Eur J Clin Nutr 2001;55:1000-7. (Pubitemid 33040098)
47. Lin J, Zhang SM, Cook NR, Manson JE, Lee IM, Buring JE, et al. Intakes of calcium and vitamin D and risk of colorectal cancer in women. Am J Epidemiol 2005;161:755-64.
48. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997;8:615-25. (Pubitemid 27330494)
49. Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL, et al. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 2007;99:1120-9. (Pubitemid 47241396)
50. Li C, Li Y, Gao LB, Wang YY, Zhou B, Lv ML, et al. Vitamin D receptor gene polymorphisms and the risk of colorectal cancer in a Chinese population. Dig Dis Sci 2009;54:634-9.
51. Park K, Woo M, Nam J, Kim JC. Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk. Cancer Lett 2006;237:199-206. (Pubitemid 43792522)
52. Wong HL, Seow A, Arakawa K, Lee HP, Yu MC, Ingles SA, et al. Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis 2003;24:1091-5. (Pubitemid 36827261)
53. Slattery ML, Wolff RK, Herrick JS, Caan BJ, Potter JD. IL6 genotypes and colon and rectal cancer. Cancer Causes Control 2007;18:1095-105. (Pubitemid 47498159)
54. Flugge J, Krusekopf S, Goldammer M, Osswald E, Terhalle W, Malzahn U, et al. Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur J Clin Pharmacol 2007;63:997-1005. (Pubitemid 47561810)
55. Grunhage F, Jungck M, Lamberti C, Berg C, Becker U, Schulte-Witte H, et al. Association of familial colorectal cancer with variants in the Ecadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis 2008;23:147-54. (Pubitemid 350302510)
56. Wang G, Li BQ, Zhou HH. [Polymorphism of vitamin D receptor Fok I and colorectal cancer risk in Chinese]. Zhong Nan Da Xue Xue Bao Yi Xue Ban [J Cent South Univ Med Sci] 2008;33:399-403.
57. Yaylim-Eraltan I, Arzu Ergen H, Arikan S, Okay E, Oztürk O, Bayrak S, et al. Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer. Cell Biochem Funct 2007;25:731-7. (Pubitemid 351202363)
58. Murtaugh MA, Sweeney C, Ma KN, Potter JD, Caan BJ, Wolff RK, et al. Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer 2006;55:35-43. (Pubitemid 44477043)
59. Ochs-Balcom HM, Cicek MS, Thompson CL, Tucker TC, Elston RC, J Plummer S, et al. Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis 2008;29:1788-93.
60. Mahmoudi T, Mohebbi SR, Pourhoseingholi MA, Fatemi SR, Zali MR. Vitamin D receptor gene ApaI polymorphism is associated with susceptibility to colorectal cancer. Dig Dis Sci 2010;55:2008-13.
61. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: IOM; 2010.
62. Slattery ML, Sweeney C, Murtaugh M, Ma KN, Caan BJ, Potter JD, et al. Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer. Int J Cancer 2006;118:3140-6.
63. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56. (Pubitemid 29205056)
64. Helzlsouer KJ. Overview of the cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 2010;172:4-9.
65. Toner CD, Davis CD, Milner JA. The vitamin D and cancer conundrum: aiming at a moving target. J Am Diet Assoc 2010;110:1492-500.
66. WHO/IARC. Vitamin D and cancer-IARC working group reports volume 5. Lyon, France: World Health Organization, International Agency for Research on Cancer; 2008.
67. Ding EL, Mehta S, Fawzi WW, Giovannucci EL. Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women's Health Initiative randomized trial. Int J Cancer 2008;122:1690-4. (Pubitemid 351413414)
68. Lagunova Z, Porojnicu AC, Grant WB, Bruland O, Moan JE. Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association? Mol Nutr Food Res 2010;54:1127-33.
69. Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:1765-71. (Pubitemid 38008899)
70. Oh K, Willett WC, Wu K, Fuchs CS, Giovannucci EL. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol 2007;165:1178-86. (Pubitemid 47233720)
71. Peterlik M, Grant WB, Cross HS. Calcium, vitamin D and cancer. Anticancer Res 2009;29:3687-98.
72. Slattery ML, Neuhausen SL, Hoffman M, Caan B, Curtin K, Ma KN, et al. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer 2004;111:750-6. (Pubitemid 39062899)
73. Satia-Abouta J, Kristal AR, Patterson RE, Littman AJ, Stratton KL, White E, et al. Dietary supplement use and medical conditions: the VITAL study. Am J Prev Med 2003;24:43-51. (Pubitemid 36110693)
74. Cross HS, Lipkin M, Kallay E. Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy. J Nutr 2006;136:561-4. (Pubitemid 43363735)
75. Ovesen L, Boeing H. The use of biomarkers in multicentric studies with particular consideration of iodine, sodium, iron, folate and vitamin D. Eur J Clin Nutr 2002;56Suppl 2:S12-S17. (Pubitemid 41726637)
76. Tangpricha V, Spina C, Yao M, Chen TC, Wolfe MM, Holick MF, et al. Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J Nutr 2005;135:2350-4. (Pubitemid 41429589)
77. Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M, et al. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 2009;30:88-92.
78. Yang K, Lamprecht SA, Shinozaki H, Fan K, Yang W, Newmark HL, et al. Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice. J Nutr 2008;138:1658-63.
79. Mokady E, Schwartz B, Shany S, Lamprecht SA. A protective role of dietary vitamin D3 in rat colon carcinogenesis. Nutr Cancer 2000;38:65-73. (Pubitemid 32377945)
80. Pendas-Franco N, Aguilera O, Pereira F, Gonzalez-Sancho JM, Munoz A. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res 2008;28:2613-23.
81. Anti M, Armuzzi A, Morini S, Iascone E, Pignataro G, Coco C, et al. Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas. Gut 2001;48:238-46. (Pubitemid 32141850)
82. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995;55:1811-6.
83. Diaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 2000;60:2304-12. (Pubitemid 30225198)
84. Fedirko V, Bostick RM, Flanders WD, Long Q, Sidelnikov E, Shaukat A, et al. Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2009;18:2933-41.
85. Fedirko V, Bostick RM, Flanders WD, Long Q, Shaukat A, Rutherford RE, et al. Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res (Phila) 2009;2:213-23.
86. Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS, et al. Calcium, vitamin D, and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev 2005;14:525-8. (Pubitemid 40270121)
87. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-96. (Pubitemid 43247139)
88. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.
89. Bischoff-Ferrari H. Health effects of vitamin D. Dermatol Ther 2010;23:23-30.
90. Pietinen P, Malila N, Virtanen M, Hartman TJ, Tangrea JA, Albanes D, et al. Diet and risk of colorectal cancer in a cohort of Finnish men. Cancer Causes Control 1999;10:387-96. (Pubitemid 29454315)
91. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer 2007;97:446-51. (Pubitemid 47196759)
92. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol 1995;142:608-11.
93. Kadiyska T, Yakulov T, Kaneva R, Nedin D, Alexandrova A, Gegova A, et al. Vitamin D and estrogen receptor gene polymorphisms and the risk of colorectal cancer in Bulgaria. Int J Colorectal Dis 2007;22: 395-400. (Pubitemid 46336243)
94. Parisi E, Reñé JM, Cardús A, Valcheva P, Piñol-Felis C, Valdivielso JM, et al. Vitamin D receptor levels in colorectal cancer. Possible role of BsmI polymorphism. J Steroid Biochem Mol Biol 2008;111:87-90.
95. Speer G, Cseh K, Winkler G, Takács I, Barna I, Nagy Z, et al. Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers. Eur J Cancer 2001;37:1463-8. (Pubitemid 32744674)
96. Slattery ML, Yakumo K, Hoffman M, Neuhausen S. Variants of VDR genes and risk of colon cancer (United States). Cancer Causes Control 2001;12:359-64. (Pubitemid 32553629)
97. Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, Sweeney C, et al. CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2752-5. (Pubitemid 351196332)
98. Flugge J, Laschinski G, Roots I, Krusekopf S. Vitamin D receptor poly (A) microsatellite and colorectal cancer risk in Caucasians. Int J Colorectal Dis 2009;24:171-5.
99. Slattery ML, Murtaugh M, Caan B, Ma KN, Wolff R, Samowitz W, et al. Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control 2004;15:863-72. (Pubitemid 39663862)